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THE eradication of malignant growths by surgery depends largely upon the
early diagnosis of the neoplasm. The need for reliable tests for malignancy has
been emphasized by Homberger (1950), who has reviewed more than 60 bio-
chemical, biological and cytological " cancer tests " which have been advocated
in the last two decades. Some of these, such as the estimation of serum acid
phosphatase (Gutman, 1942; Herbert, 1946) and the cytological examination
of fluids (Papanicolaou and Traut, 1943; Shen and Homberger, 1950), are of
great value ; others, such as the determination of erythrocyte sedimentation
rate (E.S.R.), are not specific for neoplasia.
The growth of malignant tumours involves an abnormal synthesis of tissue
which may be reflected in the serum proteins. Recently serious attention has
been given to the qualitative and quantitative changes occurring in serum pro-
teins in neoplasia. Huggins and his colleagues (Huggins, Miller and Jensen,
1949; Huggins, Jensen, Player and Hospelhorn, 1949; Huggins, Cleveland and
Jensen, 1950) have shown that the thermal coagulation of serum proteins, and
the inhibition of this coagulation by iodoacetate, is altered in neoplastic disease.
Winzler and his colleagues (Winzler, Devor, Mehl and Smyth, 1948; Winzler
and Smyth, 1948) have reported that the mucoproteins in serum may be increased
in neoplastic disease. Both groups of authors have, however, demonstrated
that these tests are not specific for neoplasia. Several reports (Pollak and
Leonard, 1950; Bodansky and McInnes, 1950; Homberger, Pfeiffer, Page,
Rizzoni and Benotti, 1950; Gilligan, Rothwell and Warren, 1950; Finnegan,
Brockland, Muether, Hawk, Inkley and Thoma, 1950) have since been published
confirming that some of these tests may not only give positive results in non-
malignant cases (i.e., false positive results), but also negative results in malignant
cases (i.e., false negative results). Few reports have, however, appeared in which
these tests have been used in conjunction with other biochemical tests of known
value, such as the estimation of serum acid phosphatase in carcinoma of the
prostate and serum alkaline phosphatase in the detection of bone diseases.
This paper records the results of an investigation of the thermal coagulation
test, the inhibition of coagulation by iodoacetate and the estimation of serum
mucoproteins in 25 normal subjects and 129 patients suffering from malignant
neoplasia and other diseases. The serum tota] protein, albumin and globulin
content, the serum phosphatases and E.S.R. have also been estimated for most
of the patients and compared with the accepted normal values. A preliminary
report of the work was communicated to the Biochemical Society (Broughton,
Higgins and O'Brien, 1951).BIOCHEMICAL TESTS FOR CANCER
METHODS AND MATERIALS.
Patients were chosen, usually before treatment, in whom the diagnosis was
proved or likely to be proved. Some with carcinoma, particularly the elderly
ones, had complicating diseases, such as chest and urinary infections.
The least concentration of coagulable protein (LCCP) and the iodoacetate
index (IAI) were determined by the method of Huggins, Miller and Jensen
(1949). In the LCCP test solutions were prepared so that the serum concentra-
tion increased in steps of 0-25 ml., and in the IAI test the iodoacetate concen-
tration was increased in steps of 1-5 FM., which were the smallest changes in con-
centration detectable in our procedure. These solutions were heated in tubes
1 cm. in diameter. In our technique the criterion of coagulation was the for-
mation of a gel sufficiently rigid to slide down the inverted tube after gentle
tapping without loss of shape.
Mucoproteins in serum were separated by the method of Winzler, Devor,
Mehl and Smyth (1948), and their protein content determined by the biuret
method of Weichselbaum (1946).
Serum proteins were determined by the micro-Kjeldahl technique (Howe,
1921). Alkaline phosphatase was determined by the method of King and Arm-
strong (1934), and acid phosphatase by the method of Gutman and Gutman
(1938). The erythrocyte sedimentation rate (E.S.R.) was determined by Wester-
gren's (1921) method. All determinations except the E.S.R. were made on serum,
and completed on the day the blood was collected.
The serum flocculation tests used were the thymol turbidity test (Maclagan,
1944b), the colloidal gold test (Maclagan, 1944a) and the Takata-ara reaction
(Ragins, 1934).
RESUILTS.
The following symbols are used in the text and tables:
T Total protein content of serum (g./100 ml.).
A Albumin content of serum (g./100 ml.).
G Globulin content of serum (g./100 ml.).
LCCP Least concentration of coagulable protein, i.e., the least concentration
of serum protein which coagulates on heating (g./100 ml.).
IAI Iodoacetate index. In this test the end-point is the largest amount of
iodoacetate (uM.) which, when added to 0-25 ml. serum, will not
inhibit thermal coagulation. Then IAI is this end-point multiplied
by 4/T.
P mg. protein in the mucoprotein present in 100 ml. serum.
B = Biopsy. . H = Bronchoscopy.
L Laparotomy. . Ad Adenocarcinoma.
N Necropsy. . TC Transitional-celled carcinoma.
Cl. Clinical diagnosis. . S Squamous-celled carcinoma.
R Radiological diagnosis. D Spheroidal-celled carcinoma.
M' Malignant cells in . Y Leiomyosarcoma.
pleural fluid.
The numbers in the histology column refer to 'Broders' (1925) grading. The
diagnosis of malignancy was confirmed by laparotomy, necropsy, histological or
radiological examination in 80 cases.
385386 P. M. G. BROUGHTON, G. HIGGINS AND J. R. P. O BRIEN
TABLE I.-Normal Ranges for the Least Concentration of Coagulable Protein, the
Iodoacetate Index and Serum Mucoprotein Concentration.
Test. No. of analyses. Range.
LCCP . . . 32 . 119-1.59 g./100 ml.
IAI . . . 30 . 73-13-6 units
P . . . . 32 . 40-93 mg./100 ml.
(For symbols see p. 385.)
Normal subjects.
Table I shows the range of values for the thermal coagulation and iodoacetate
tests and the estimation of mucoprotein obtained in 32 analyses on a group of
11 females and 14 males, of ages ranging from 20 to 40 years (mean age 26).
The normal range for alkaline phosphatase was taken as 4-14units/100 ml.,
total protein 6-3-7-8 g./100 ml., albumin 4 0-5 2 g./100 ml., globulin 1-3-2-9 g./
100 ml. (Higgins and O'Brien, unpublished data), acid phosphatase 1-5 units/100
ml. (Gutman and C-utman, 1938), and E.S.R. 1-1( mm./hour (Westergren, 1921).
Hospital patients.
Tables II to VIII show the values for the thermal coagulation test, iodoacetate
index and mucoprotein concentration, together with the serum proteins, of a
group of 82 patients with malignant diseases and 47 patients with non-malignant
diseases. The malignant group contained 11 cases ofcarcinomatosis, 16 neoplasia
of bronchus and oesophagus, 15 neoplasia of gastro-intestinal tract, 20 neoplasia
ofprostate and bladder, 6neoplasia ofbiliary tract and 14 miscellaneous malignant
diseases. The non-malignant group contained 7 cases of chest infection, 14
benign prostatic hyperplasia, 12 hepatic diseases and 14 miscellaneous diseases.
Table IX records the summary of the results given in Tables II to VIII. It
will be seen from this table that none of these tests is completely reliable in the
detection of malignancy; all tests gave false positive and false negative results.
The LCCP test gave 82 per cent correct positive results in the malignant group,
but 62 per cent false positives in the non-malignant group. Similarly the IAI
gave 55 per cent correct positive results and 38 per cent false positive results,
while the mucoprotein concentration was abnormal in 73 per cent ofthe malignant
cases, but also 48 per cent of the non-malignant cases.
The least concentration of coagulable globulin and the actual amount of
iodoacetate added have also been investigated but yielded no additional informa-
tion.
Youden (1950) has proposed an index for assessing the value of diagnostic
tests. These indices were calculated for LCCP, IAI and mucoprotein (P), but
differences between them were not significant and they have not therefore been
reported.
('orrelation of results.
None of the three tests, LCCP, IAI and P, detected one histological type of
neoplasia better than another, and it was impossible from their results to deter-
mine whether the more rapidly growing neoplasms produced greater changes in
the serum. Their degree of positivity in cases of widespread carcinomatosis was
often no greater than that in cases of single neoplasm,BIOCHEMICAL TESTS FOR CANCER 387
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TABLE IX.-Sumrrnary of Results.
(First
Group.
Infective hepatitis
Hepatic cirrhosis
Benign prostate
Miscellaneous non-malignant.
Carcinomatosis
Carcinoma of bronchus
,, 9 oesophagus
,15, prostate
bladder
stomach
colon
rectum
Jaundice due to malignant growtl
Miscellaneous malignant
TOTAL NON-MALIGNANT
, MALIGNANT.
% MALIGNANT CORRECT
,, NON MALIGNANT ,,
analysis oin each patient only.)
LCCP. IAI.
+ - + _
2 4
6 0
9 5
12 9
11 0
12 1
2 1
10 4
5 1
4 1
4 1
4 1
6 0
9 5
29 18
67 15
+ ve 82 -
-Ve - 38
2
10 6
9
10
10
1
5
3
4
2
3
1
6
18
45
55
5
4
8
12
1
3
2
9)
3
1
3
2
5
8
29
37
62
1' E.S.R.
± -
1
0
9
12
11
12
3
8
4
4
4
3
3
8
22
60
73
5
6
5
8
1
0
6
2
1
1
2
3
6
24
2-)
52
0
3
3
8
9
0
6
2
2
1
2
7
14
33
77
0
0
3
5
0
0
3
1
2
0
2
1
1
8
10
36
(For symnbols see p. 385.)
The total protein, albumin and globulin content of sera from malignant and
non-malignant cases were not significantly different. There was no obvious
correlation between the serum protein concentrations and results of heat coagu-
lation, mucoprotein or E.S.R. tests, but there was a higher proportion of positive
IAI tests in sera from all cases with a low total protein content. This is illus-
trated in Table X.
TABLE X.-Relationship between Iodoacetate Index and Total Protein Concentration
(all cases).
'rotal protein
(g./100 ml.).
<5*5
5 5-559
6 0-6 4
6 5-6 9
7 0-7 4
>7-4
No. of % +V03
cases. IAI test.
8 . 100
30
37
23
21
5
70
41
39
38
0
An increase in the alkaline phosphatase was usually associated with positive
cancer tests," but no single test appears to be directly correlated with this
enzyme. The serum alkaline phosphatase was raised in cases of carcinoma of
the bronchus (Table Illa, No. 13, 17, 18, 19, 20 21), stomach (Table IVa, No.
32), colon (Table IVb, No. 34), rectum (Table JVc, No. 38, 39 and 41),
prostate (Table VIa), and biliary tract (Table VII).
The serum acid and alkaline phosphatase concentrations of all patients with
benign prostatic hypertrophy were normal, but 10 of the 14 cases with carcinoma
of the prostate showed a raised acid phosphatase, and 10 a raised alkaline phos-
phatase. These raised phosphatase levels are useful in indicating the presenceBIOCHEMICAL TESTS FOR CANCER
of secondary bone deposits, but like the other tests, they are not of much value
in detecting an early carcinoma of the prostate.
The E.S.R. was raised in 80 to 90 per cent of cases (malignant and non-
malignant) which gave one or more positive results in the three "cancer tests,"
but it was raised in 3 cases (TableIlla, No. 15; TableIVb, No. 33; Table VIIIa,
No. 104) which gave negative results. Patients with a normal E.S.R., however,
did not necessarily give normal results in these tests.
DISCUSSION.
The results of this investigation show some of the weaknesses of biochemical
tests that have been advocated as diagnostic aids in neoplasia. They agree
substantially with others which appeared during the present work (Huggins,
Miller and Jensen, 1949; Huggins, Cleveland and Jensen, 1950; Jackson, 1950;
Pollak and Leonard, 1950; Duboff, 1950; Bodansky and McInnes, 1950;
Homberger, Pfeiffer, Page, Rizzoni and Benotti, 1950; Winzler and Smyth,
1948; Kelley, Good and McQuarrie, 1950; Gilligan, Rothwell and Warren,
1950; Finnegan, Brockland, Meuther, Hawk, Inkley and Thoma, 1950). The
heat coagulation, iodoacetate and mucoprotein tests, which were studied in this
work, are not sufficiently sensitive to detect incipient tumours, are not sufficiently
reliable to exclude or to confirm a diagnosis, and generally speaking, their response
is not proportional to the severity of the disease. In a variety of diseases they
give false positive results. For instance, in the present series false positive results
were obtained in bronchitis, cystitis, infective hepatitis, cirrhosis and actino-
mycosis. Of all the tests, the acid phosphatase activity of the serum appears
the most useful in that it helps in the diagnosis of carcinoma of the prostate with
metastases.
In various diseases the three tests gave results which conformed to a general
pattern, but they differed in their sensitivity towards the change in the serum.
Usually they acted similarly, giving either positive or negative results. This
behaviour was not invariable, for in some diseases such as cirrhosis, positive heat
coagulation tests occurred with normal mucoprotein concentration. It is, there-
fore, possible that the tests measure different changes which usually occur at
the-same time or different aspects ofone change.
In carcinomatosis, the thermal coagulation (LCCP), the iodoacetate test
(IAI) and the mucoprotein test (P) were consistently positive, but their degree
of positivity appeared unrelated to the extent of the malignant invasion. For
instance, in Case 8 (Table II), of which massive metastases were a feature, LCCP
was only slightly abnormal and IAI borderline. There is usually little doubt
about the diagnosis of carcinomatosis, but the detection of a single neoplasm
is more difficult and urgent. In cases of carcinoma of bronchus (Table IlIa,
No. 15), carcinoma of stomach (Table IVa, No. 31), carcinoma of colon (Table
IVb, No. 33), carcinoma of rectum (Table IVc, No. 39), carcinoma of prostate
(Table VIa, No.48, 50), carcinoma of breast (Table Vllla, No. 92), epithelioma
of lip (Table VIIIa, No. 94) and carcinoma of penis (Table VIIIa, No. 95),
all three tests have given completely negative results. This failure of the tests
shows up their limitations, and suggests that neither one test nor a combination
ofthem would detect with any certainty neoplasia in an early stage ofits growth.
It would seem that serum undergoes changes during an infection somewhat
similar to those in malignant disease. For in most ofour eases ofnon-malignant
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disease infection was a feature, and in the majority of them the three tests gave
positive results. The positivity of the tests bore no relation to the severity of
the infection, so that it was impossible to judge the contribution infection might
be making to any result on a malignant case. In this respect flocculation tests
and white cell counts gave no help. It is therefore not surprising that the tests
did not differentiate between carcinoma of the bronchus and chronic chest infec-
tions. However, it will be observed that whereas the value ofthe serum alkaline
phosphatase was within the normal range in the non-malignant group, it was
abnormal in 6 ofthe 13 cases ofcarcinoma ofbronchus.
No biochemical test has so far been suggested for differentiating benign hyper-
plasia and malignant disease ofthe prostate, although the serum acid phosphatase
determination is of value in establishing the diagnosis of secondary metastases.
In this survey (Table VIa, b) the heat coagulation and iodoacetate tests and the
estimation of mucoproteins gave normal and abnormal results in both groups.
In view of the effect of infections upon these tests it would be expected that
positive results would occur in the non-malignant group, since many of these
elderly men had chronic infections as well as enlarged prostates. The serum
proteins were of no practical value in differentiating the two conditions, but the
serum acid phosphatase was raised in 10 of the 14 cases of carcinoma of the pro-
state and in none of the cases of benign hyperplasia. The E.S.R. was increased
in 6 of the 9 cases of malignant prostate and in 3 of the cases of benign hyper-
plasia. It would appear that the serum acid phosphatase remains the most
useful ofthe tests used in this survey in establshing the diagnosis of metastases,
although it is of little value in the detection of early carcinoma of the prostate.
In the experience of the authors (Higgins and O'Brien, unpublished data) a
small proportion of cases of infective hepatitis and cirrhosis give results which
do not fit in with the general biochemical picture, and occasional sera from cases
of obstructive jaundice show alkaline phosphatase levels which confuse rather
than clarify the diagnosis; such a case is No. 128 (Table VIJa). In these cases
weight is given to the flocculation tests, but even these often give borderline
results, especially in cases ofobstructive jaundice oflong duration. It was in the
hope of aiding the diagnosis of these cases that the heat coagulation, iodoacetate
and mucoprotein tests were done in 6 cases of infective hepatitis, 6 of cirrhosis
and 6 of malignant obstruction. The results have not added to the certainty
of diagnosis. The heat coagulation test was positive in all cases of malignancy,
but was also positive in all 6 cases ofcirrhosis and in 2 cases ofinfective hepatitis.
When sera from some cases ofcirrhosis were heated the resulting gels were turbid
and consisted oftwo phases-a solid protein " curd " and water. These solutions
were similar to those produced byJensen, Hospelhorn, Tapley and Huggins (1950)
on heating albumin in acid solution. These gels were quite different from those
obtained from normal sera, and the heat coagulation and iodoacetate tests have,
therefore, little meaning with these solutions. The mucoproteins show some
unexpected results in that positive results were obtained in one very serious case
and one very mild case of hepatitis (Table VIIb, No. 78, 79), negative results
in the cirrhosis group, and variable results in the malignant group.
Physical, chemical, enzymatic and immunological investigations have shown
the diversity of change in relative proportions and in their nature which plasma
proteins undergo in disease. Even more subtle changes may yet be revealed as
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a general response of the body to disease or one peculiar to one disease, is still to
be decided. Of the tests which have been described, the positive response of the
iodoacetate test has been attributed to changes in the molecules of protein pro-
duced by the body in repsonse to stress of illness (Bodansky and McInnes, 1950).
Another suggestion is that the iodoacetate test provides an index oftissue destruc-
tion or some form of trauma. These views may be applied to other "cancer
tests," and if true would rob them of real value as diagnostic aids in cancer. If
some general metabolic change is responsible for positive results in these tests, it
is not surprising that abnormal results are found in diseases other than cancer.
Nor is it surprising that some sera from cancer patients give normal results, since
it is difficult to understand how some isolated neoplasm, such as epithelioma of
the lip, could affect protein metabolism.
Of the changes in plasma proteins in disease and of many of the reactions
used to reveal them there is still much to be learned. The deficiency in thermal
coagulation, as shown by the heat test, may be due to an alteration in the albumin
molecule, which is possibly associated with a change in the number of free sul-
phydryl groups. No gross change in the amino-acid composition of the albumin
in these sera has been detected (Huggins, Jensen, Player and Hospelhorn, 1949).
Heat denaturation of protein may, however, involve a breaking of hydrogen
bonds which hold the protein molecule in its natural form, thus cau$ing the altera-
tion in its configuration and the formation of new hydrogen bonds between car-
boxyl and amino groups in neighbouring polypeptide chains (Mirsky and Paul-
ing, 1936). Possibly the protein molecule, produced by the body in response to,
or because of, the disease, differs from the normal protein in its arrangement of
the amino-acid groups, resulting in a different molecular pattern and a differing
availability of the carboxyl and amino groups. Jensen, Hospelhorn, Tapley and
Huggins (1950) have suggested that iodoacetate reacts with the sulphydryl
groups in the albumin molecule, thus introducing a negatively charged carboxyl
ion which prevents lateral binding of protein molecules on heating, and that this
inhibits coagulation. The decreased amount of iodoacetate necessary to prevent
coagulation of sera from diseased patients may be associated with a decreased
number of sulphydryl groups. This theory is supported by the report of Schoen-
bach, Weissman and Armistead (1951) that the sulphydryl content of serum
protein from some patients with malignant and other diseases is subnormal.
However, as shown in Table XI, a decreased serum protein concentration is
usually associated with a positive iodoacetate test. Similar effects were noted
by Huggins, Miller and Jensen (1949) and Duboff (1950). It would therefore
appear that the reaction is not a simple combination with sulphydryl gtoups.
It is possible that electrostatic forces in the protein-depleted serum are altered
so that less iodoacetate is required to bring about a sufficiently negative charge
to hinder coagulation. With the elucidation of points such as these, the value
of biochemical tests in diagnosis may eventually be properly assessed.
Whatever may be the nature ofthe change in the protein molecule responsible
for the abnormal results of heat coagulation, iodoacetate and mucoprotein tests,
it occurs in malignant and non-malignant disease to an extent often dispropor-
tionateto the severityofthe disease. The tests like the E.S.R. indicate anabnor-
mality ofunspecific and as yet undefined nature. Added to this weakness, they
often give negative results in cases of neoplasia so that they have little value as
"screening tests." Of the other determinations made in this investigation, the
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serum protein concentration is of little value in the differential diagnosis of
malignant disease, and in many cases no guide to the severity of the condition.
The acid phosphatase is of value in the diagnosis of carcinoma of the prostate
with metastases, and the alkaline phosphatase a useful aid in the diagnosis of
liver or bone disease.
In future work it is hoped to investigate more closely the nature ofthe change
in the plasma protein in malignant disease and to correlate it with biochemical
studies upon biopsy specimens.
SUMMARY.
1. The heat coagulation and iodoacetate tests and estimation ofmucoproteins
have been performed, together with other biochemical tests, upon 25 normal
subjects, 82 patients with neoplasia and 47 patients with non-malignant diseases.
2. The heat coagulation test (LCCP) was positive in 82 per cent of carcinoma
cases and 62 per cent ofnon-malignant cases.
3. The iodoacetate test (IAI) was positive in 55 per cent of carcinoma cases
and 38 per cent ofnon-malignant cases.
4. The mucoprotein concentration (P)wasincreasedin 73per centofcarcinoma
cases and 48 per cent ofnon-malignant cases.
5. No correlation was found between the degree of positivity of these tests
and histology or extent of the carcinoma. The iodoacetate test, however, ap-
peared to berelated to the serum protein concentration.
6. This survey shows that these tests add little to the laboratory diagnosis of
cancer.
The authors' thanks are due to the consultant staff of the United Oxford
Hospitals for permission to quote from the notes of their patients, and for details
ofprivate cases, to Dr. A. H. T. Robb-Smith for permission to quote from patho-
logical reports, and to members of the staff of this department for valuable''
advice, help and criticism during this work.
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